syringic acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Velu, P; Vijayalakshmi, A; Vinothkumar, V | 1 |
1 other study(ies) available for syringic acid and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Gallic Acid; Humans; Inflammation Mediators; Mouth Neoplasms; Neoplasm Invasiveness; NF-kappa B; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Squamous Cell Carcinoma of Head and Neck | 2020 |